Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Immunologic Research|June 14, 2000
Antibodies in human infectious diseaseP W Parren, P Poignard, H J Ditzel, et al.Journal of Immunological Methods|June 23, 1997
Pilot scale purification of human monoclonal IgM (COU-1) for clinical trialsI Tornøe, I L Titlestad, K Kejling, et al.Immunotechnology : an International Journal of Immunological Engineering|May 1, 1995
Human monoclonal Fab fragments specific for viral antigens from combinatorial IgA librariesI Moreno de Alborán, C Martínéz-alonso, C F Barbas, et al.Annals of the Rheumatic Diseases|October 2, 2004
Raised levels of anti-glucose-6-phosphate isomerase IgG in serum and synovial fluid from patients with inflammatory arthritisM Schaller, W Stohl, S M Tan, et al.Tissue Antigens|March 21, 2014
SSX2-4 expression in early-stage non-small cell lung cancerK B V Greve, M Pøhl, K E Olsen, et al.Proceedings of the National Academy of Sciences of the United States of America|March 28, 1995
Human autoantibody recognition of DNAS M Barbas, H J Ditzel, E M Salonen, et al.Oncogene|September 23, 2018
Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapyD Elias, H Vever, A-V Lænkholm, et al.AIDS Research and Human Retroviruses|July 1, 1996
Human antibody responses to HIV type 1 glycoprotein 41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen bindingJ M Binley, H J Ditzel, C F Barbas, et al.Oncogene|June 3, 2014
Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapyD Elias, H Vever, A-V Lænkholm, et al.Oncogene|November 13, 2019
Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapyD Elias, H Vever, A-V Lænkholm, et al.Pageof 3